A monovalent agonist of TrkA tyrosine kinase receptors can be converted into a bivalent antagonist.
about
Combinatorial assembly of small molecules into bivalent antagonists of TrkC or TrkA receptors.The Paradoxical Signals of Two TrkC Receptor Isoforms Supports a Rationale for Novel Therapeutic Strategies in ALS.Comparison of nerve growth factor receptor binding models using heterodimeric muteins.A Pro-Nerve Growth Factor (proNGF) and NGF Binding Protein, α2-Macroglobulin, Differentially Regulates p75 and TrkA Receptors and Is Relevant to Neurodegeneration Ex Vivo and In Vivo.
P2860
A monovalent agonist of TrkA tyrosine kinase receptors can be converted into a bivalent antagonist.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A monovalent agonist of TrkA t ...... ed into a bivalent antagonist.
@ast
A monovalent agonist of TrkA t ...... ed into a bivalent antagonist.
@en
A monovalent agonist of TrkA t ...... ed into a bivalent antagonist.
@nl
type
label
A monovalent agonist of TrkA t ...... ed into a bivalent antagonist.
@ast
A monovalent agonist of TrkA t ...... ed into a bivalent antagonist.
@en
A monovalent agonist of TrkA t ...... ed into a bivalent antagonist.
@nl
prefLabel
A monovalent agonist of TrkA t ...... ed into a bivalent antagonist.
@ast
A monovalent agonist of TrkA t ...... ed into a bivalent antagonist.
@en
A monovalent agonist of TrkA t ...... ed into a bivalent antagonist.
@nl
P2093
P2860
P1476
A monovalent agonist of TrkA t ...... ed into a bivalent antagonist.
@en
P2093
Andrey Malakhov
Antoine Caron
Enrico O Purisima
Fouad Brahimi
H Uri Saragovi
Kevin Burgess
Ljubica Ivanisevic
Shafinaz Chowdhury
P2860
P304
P356
10.1016/J.BBAGEN.2010.06.007
P407
P577
2010-06-19T00:00:00Z